In March 2025, the company introduced new plans for any direct-to-client offering of its Wegovy weight loss drug. The company founded a brand new pharmacy, known as NovoCare, which would charge buyers $499 every month for usage of the drug, a lot less than 50 percent the expense of the drug by o